M

MRK

Merck & Co

82.74

2.90+3.63%
After Hours: 82.60  -0.14  -0.17%19:54 04/25 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Total Assets

117.11B

106.67B

109.16B

105.69B

91.59B

Total Current Assets

38.78B

32.17B

35.72B

30.27B

27.76B

Total Non Current Assets

78.32B

74.51B

73.44B

75.43B

63.82B

Total Liabilities

70.73B

69.04B

63.10B

67.44B

66.18B

Total Current Liabilities

28.42B

25.69B

24.24B

23.87B

27.33B

Total Non Current Liabilities

42.31B

43.35B

38.86B

43.56B

38.86B

Total Equity

46.37B

37.63B

46.06B

38.26B

25.40B

Total Stockholders Equity

46.31B

37.58B

45.99B

38.18B

25.32B

Minority Interest

59.00M

54.00M

67.00M

73.00M

87.00M

Total Liabilities & Shareholders Equity

117.11B

106.67B

109.16B

105.69B

91.59B

Total Common Shares Outstanding

2.53B

2.53B

2.54B

2.53B

2.53B

Total Preferred Shares Outstanding

--

--

--

--

--